Feasibility and Effectiveness of an Evidence-Based Asthma Service in Australian Community Pharmacies: A Pragmatic Cluster Randomized Trial

Journal of Asthma

Volumn 50, Issue 3, 2013, Pages 302-309

  Armour, Carol L ^a   Reddel, Helen K ^a   Lemay, Kate S ^a   Saini, Bandana ^a   Smith, Lorraine D ^a   Bosnic Anticevich, Sinthia Z ^a   Song, Yun Ju Christine ^b   Alles, M Chehani ^a   Burton, Deborah L ^e   Emmerton, Lynne ^d   Stewart, Kay ^c   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e CENTRAL QUEENSLAND UNIVERSITY   (Australia)

Author keywords

Asthma; Asthma control; Disease management; Pharmacy services; Primary care

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADULT; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; AUSTRALIA; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; COMMUNITY PHARMACY; CONSULTATION; CONTROLLED STUDY; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE DELIVERY; HEALTH SERVICE; HOSPITAL DEPARTMENT; HOSPITAL PHARMACY; HUMAN; INHALER; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL SOCIETY; NORMAL HUMAN; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PHARMACIST; PHARMACY; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SPIROMETRY; SUSTAINABLE DEVELOPMENT;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; AUSTRALIA; CLUSTER ANALYSIS; FEASIBILITY STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; PHARMACIES; PHARMACISTS; QUALITY OF LIFE; VITAL CAPACITY;

EID: 84874830010     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.754463     Document Type: Review

References (28)

1. Australian Centre for Asthma Monitoring. 2011. Asthma in Australia 2011. AIHW Asthma Series no. 4. Cat. No. ACM 22. Canberra: AIHW.
2. Armour C, LeMay K, Saini B, Reddel HK, Bosnic-Anticevich SZ, Smith LD, Burton D, Song YJ, Alles MC, Stewart K, Emmerton L, Krass I. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma 2011; 48(9):914-922.
3. Marks G, Abramson M, Jenkins C, Kenny P, Mellis CM, Ruffin RE, Stosic R, Toelle BG, Wilson DH, Xuan W. Asthma management and outcomes in Australia: a nation-wide telephone interview survey. Respirology 2007; 12(2):212-219.
4. Burton C, Proudfoot J, Amoroso C, Ramsay E, Holton C, Bubner T, Harris M, Beilby J. Management of asthma in Australian general practice: care is still not in line with clinical practice guidelines. Prim Care Respir J 2009; 18(2):100-105.
5. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62(6):496-502.
6. Gordois A, Armour C, Brillant M, Bosnic-Anticevich S, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Cost-effectiveness analysis of a Pharmacy Asthma Care Program in Australia. Dis Manag Health Out 2007; 15(6):387-396.
7. Saini B, Krass I, Armour CL. Specialisation in Asthma: current practice and future roles-A qualitative study of practising community pharmacists. J Soc Admin Pharm 2001; 18:169-177.
8. Kritikos VS, Reddel HK, Bosnic-Anticevich SZ. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services. Int J Pharmacy Practice 2010; 18:209-216.
9. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009; 43(1):85-97.
10. Bunting BA, Cranor CW. The Asheville project: long term clinical, humanistic and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006; 46(2):133-147.
11. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003; 10(4):195-202.
12. Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004; 38(11):1954-1960.
13. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21(10):1196-1203.
14. Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau TJ, Ersboell BK. Improving drug therapy for patients with asthma-part 1: Patient outcomes. J Am Pharm Assoc 2001; 41(4):539-550.
15. Ware JH, Hamel MB. Pragmatic trials-guides to better patient care? N Engl J Med 2011; 364(18):1685-1687.
16. National Asthma Council Australia. Asthma Management Handbook 2006. Melbourne: NAC; 2006.
17. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992; 45(5): 461-472.
18. Katz PP, Yelin EH, Eisner MD, Blanc PD. Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 2002; 89(3):251-258.
19. Kritikos V, Krass I, Chan HS, Bosnic-Anticevich SZ, Validity T. Reliability of two Asthma Knowledge Questionnaires. J Asthma 2005; 42(9):795-801.
20. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37(2):113-124.
21. Juniper E, O'Byrne P, Guyatt G, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14(4):902-907.
22. Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
23. O'Connor J, Seeto C, Saini B, Bosnic-Anticevich S, Krass I, Armour C, Smith L. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns 2008; 70(1):111-117.
24. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Ass 2003; 43(2):173-184.
25. Meltzer EO, Busse WW, Wenzel SE, Belozeroff V, Weng HH, Feng J, Chon Y, Chiou CF, Globe D, Lin SL. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011; 127(1):167-172.
26. Juniper E, Svensson K, Mörk AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99(5):553-558.
27. Gibson P, Powell H, Coughlan J, Wilson AJ, AbramsonM, Haywood P, Bauman A, Hensley MJ, Walters EH. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2009, 3.
28. Hammerlein A, Muller U, Schulz M. Pharmacist-led intervention study to improve inhaler technique in asthma and COPD patients. J Eval Clin Pract 2011; 17:61-70.